MedPath

Epidemiological Screening of IL10RA Mutation Rate in China

Withdrawn
Conditions
Digestive System Disease
Registration Number
NCT03097731
Lead Sponsor
Children's Hospital of Fudan University
Brief Summary

The presentation of IBD in early childhood is uncommon and the monogenetic defects, especially IL-10 signaling pathway play a key role in very early onset inflammatory bowel disease (VEO-IBD). IL-10 or IL-10R deficiency associated VEO-IBD is considered a rare disorder. To date, there were about 60 cases were reported all over the word. But in our Chinese VEO-IBD Collaboration Group, 42 patients with biallelic mutations affecting IL10R genes were identified from 93 VEO-IBD patients, and the mutation sites are highly concentrated, including 83.9% (26/31) with p.R101W and 55% p.T179T (17/31) mutation, and the proportion of patients from Henan( A province of China) is higher. So we speculate that IL-10RA mutation may not be very rare, and the frequency of heterozygote subjects might be higher than suspected.

Detailed Description

1. The mutation rates of p.R101W and p.T179T IL10RA in Henan newborn.

2. Is there any clinical symptoms in children with IL-10RA-deficient? and the onset of the symptoms.

3. Whether the intestinal permeability is normal in heterozygote subjects.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • In the study period, all newborns in the selected hospita
Exclusion Criteria
  • Children whose guardian refused to participate in the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The mutation rate of IL-10RA in chineseFrom birth to 3 years old

All present mutations in IL-10RA

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Children's hospital of Fudan university

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath